2 ms·
Just to be clear, the study that you are quoting isn't about Sars-Cov 2. This is a quote from a 2016 paper on other respiratory diseases.
by James_Henry 6y ago
Just to be clear, the study that you are quoting isn't about Sars-Cov 2. This is a quote from a 2016 paper on other respiratory diseases.
- James_Henry 6y agoAnd here is the quote in context, not that this isn't about Covid-19: "High dose vitamin D administration in ventilated intensive care unit patients: A pilot double blind randomized controlled trial In the study, patients with vitamin D deficiency (<20ng/ml) were divided into three groups: A placebo group, and two groups that were given different doses of vitamin D. The single administration of 250,000 IU of vitamin D was compared with the single administration of 500,000 IU of vitamin D by injection. In addition, the vitamin D levels were increased to 45 and 55 ng/ml, respectively. While the length of stay of the placebo group at the ICU was 36 days, the 250,000 IU group averaged 25 days and the 500,000 IU group averaged 18 days. This is a smooth halving and means that vitamin D is useful not only in prevention but also in acute cases."